Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03901469
Title A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer (TNBC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Zenith Epigenetics

triple-receptor negative breast cancer


Talazoparib + ZEN-3694

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Recruiting Gilbert Arizona 85234 United States Details
University of Kansas Cancer Center Recruiting Westwood Kansas 66203 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
University of Pennsylvania Recruiting Philadelphia Pennsylvania 19104 United States Details
Tennessee Oncology (Sarah Cannon) Recruiting Nashville Tennessee 37203 United States Details
MD Anderson Recruiting Houston Texas 77030 United States Details
Institut Jules Bordet Recruiting Brussels 1000 Belgium Details
UZ Leuven Recruiting Leuven 3000 Belgium Details
Vall d'Hebron Institute of Oncology (VHIO) Recruiting Barcelona Spain Details
START Madrid Recruiting Madrid Spain Details
*Shaded cells indicate that there was no data available from for the field